Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy

Urologia Internationalis

Volumn 88, Issue 2, 2012, Pages 225-231

  Kuroda, Kenji ^a   Asakuma, Junichi ^a   Horiguchi, Akio ^a   Tasaki, Shinsuke ^a   Yoshii, Hidehiko ^a   Sato, Akinori ^a   Ito, Keiichi ^a   Seguchi, Kenji ^a   Sumitomo, Makoto ^a   Asano, Tomohiko ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Chemotherapy; Extravesical tumor recurrence; Lymphovascular invasion; Pathological tumor stage; Upper urinary tract; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CLINICAL FEATURE; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; URETER; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84859429759     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000335274     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ: Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology 2010; 75: 328-332.
3. Cho DS, Hong SY, Kim YK, Kim SI, Kim SJ: Prognostic factors in transitional cell carcinoma of the upper urinary tract after radical nephroureterectomy. Korean J Urol 2011; 52: 310-316.
4. Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH: The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 2009; 182: 451-458; discussion 458.
5. Simsir A, Sarsik B, Cureklibatir I, Sen S, Gunaydin G, Cal C: Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status. Int Urol Nephrol 2011; 43: 1039-1045.
6. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG: Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998; 52: 594-601. (Pubitemid 28440164)
7. Park S, Hong B, Kim CS, Ahn H: The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004; 171: 621-625. (Pubitemid 38090443)
8. Kikuchi E, Horiguchi Y, Nakashima J, Hatakeyama N, Matsumoto M, Nishiyama T, Murai M: Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 2005; 174: 2120-2123; discussion 2124. (Pubitemid 41611749)
9. Vassilakopoulou M, de la Motte Rouge T, Colin P, Ouzzane A, Khayat D, Dimopoulos MA, Papadimitriou CA, Bamias A, Pignot G, Nouhaud FX, Hurel S, Guy L, Bigot P, Roumiguie M, Roupret M, for the French collaborative national database on UUT-UCC: Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): Results From a Large Multicenter Collaborative Study. Cancer 2011; 117: 5500-5508.
10. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002; 296: 1883-1886. (Pubitemid 34596277)
11. Alitalo K, Mohla S, Ruoslahti E: Lymphangiogenesis and cancer: meeting report. Cancer Res 2004; 64: 9225-9229. (Pubitemid 39665539)
12. Akao J, Matsuyama H, Yamamoto Y, Hara T, Kawai Y, Sakano S, Ohmi C, Gondo T, Naito K: Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer. BJU Int 2008; 102: 572-575.
13. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG; Upper Tract Urothelial Carcinoma Collaboration: Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-1233.
14. Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martinez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF: Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 2010; 57: 1064-1071.
15. Lee SE, Hong SK, Han BK, Yu JH, Han JH, Jeong SJ, Byun SS, Park YH, Choe G: Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract. Jpn J Clin Oncol 2007; 37: 49-55. (Pubitemid 47090723)
16. Hung PH, Shen CH, Chiu YL, Jong IC, Chiang PC, Lin CT, Hung KY, Tsai TJ: The aggressiveness of urinary tract urothelial carcinoma increases with the severity of chronic kidney disease. BJU Int 2009; 104: 1471-1474.
17. Kaag MG, O'Malley RL, O'Malley P, Godoy G, Chen M, Smaldone MC, Hrebinko RL, Raman JD, Bochner B, Dalbagni G, Stifelman MD, Taneja SS, Huang WC: Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 2010; 58: 581-587.
18. Kwak C, Lee SE, Jeong IG, Ku JH: Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 2006; 68: 53-57. (Pubitemid 44037725)
19. Soga N, Arima K, Sugimura Y: Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Int J Urol 2008; 15: 800-803.